Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the ebmt

HIGHLIGHTS

• who: Maria H. Gilleece from the (UNIVERSITY) have published the Article: Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT, in the Journal: (JOURNAL)
• what: The authors report the first large series of transplant outcomes in 1042 adults with AML in CR2 with an established MRD status at transplant.
• how: To test for a center effect the authors introduced a random effect or frailty for each center into the model5455.
• future: The use . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.